Duvic M. Epigenetic approaches. Histone deacetylase inhibitors: vorinostat. A new treatment option for advanced cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2024 May 8];3(1). Available from: https://www.pagepress.org/journals/hmr/article/view/525